Great Bay Bio — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

A biotech firm creating antibody therapies for oncology and immunology using advanced discovery platforms.

OncologyImmunology

Proprietary fully human antibody discovery platforms, including phage display and single B-cell cloning technologies.

Potential to address underserved patient populations with novel antibody mechanisms of action.

Heavy reliance on early-stage data and need for significant capital to advance pipeline through clinical trials.

Competes in a crowded antibody therapeutics market with numerous well-funded Chinese and international biotechs.